Kits Eyecare (TSX: KITS) is expecting strong first quarter 2025 financial results, announcing this morning that it has increased its adjusted EBITDA guidance for the quarter.
Adjusted EBITDA is now expected to be within a range of 6% to 8% of revenue, compared to the prior range provided of 4% to 6%. Revenue guidance has meanwhile remained unchanged, at a range of $46 to $48 million. Revenue as a result is expected to post a growth rate of between 32% and 38% on a year over year basis.
READ: KITS Eyecare Reverses Fortune To An Annual Net Income In 2024, 32% Revenue Jump
Sponsored · Antimony Resources
“We are seeing significant traction in new glasses customers as our latest collections resonate with first-time buyers and drive repeat purchases among existing customers. Consumption per customer remains strong as customers recognize the quality and value of our offering,” commented KITS CEO Roger Hardy.
Kits Eyecare last traded at $9.09 on the TSX.
Information for this story was found via the sources and companies mentioned. The author has no securities or affiliations related to the organizations discussed. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.
